Clinical Trial Update: Staphylococcus Aureus Toxoids Phase 1-2 Vaccine Trial [Phase 1, Phase 2]

View source ↗

Summary

Phase 1-2 clinical trial evaluating a Staphylococcus aureus toxoid vaccine completed; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Infection

Drugs mentioned

• Staphylococcus aureus toxoid vaccine (Staphylococcus aureus toxoid vaccine)

Snippet

Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine | Conditions: Staphylococcus Aureus | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-12-12